{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-000510","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2022-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.424460+00:00","generated_at":"2026-06-27T21:04:27.555896+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Liquidia appoints Roger Jeffs as CEO; deGoa stays on board through Jan 31","bullets":["Roger Jeffs, Ph.D., appointed CEO effective Jan 3, 2022; replaces Damian deGoa who remains director through Jan 31.","Jeffs previously co-CEO/president of United Therapeutics (18 yrs); co-founder/vice chairman of Kriya Therapeutics.","Employment terms: $650k base salary, 50% annual bonus target, options for 1.68M shares (sign-on) and 0.93M shares (tranche 2).","DeGoa provided transition support; board chairman cited Jeffs' rare disease and pulmonary hypertension expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-000510","json":"https://secwatch.observer/filing/0001104659-22-000510.json","markdown":"https://secwatch.observer/filing/0001104659-22-000510.md","text":"https://secwatch.observer/filing/0001104659-22-000510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922000510/0001104659-22-000510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922000510/tm221309d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T21:04:27.555896+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f04bb147b","claim":"Roger A. Jeffs, Ph.D. was appointed as Chief Executive Officer at Liquidia Corp.","evidence_excerpt":"Roger A. Jeffs, Ph.D. was appointed by the Board of Directors (the “Board”) of Liquidia Corporation, a Delaware corporation (the “Company”), as the Company’s Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922000510/0001104659-22-000510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"8191accb29","claim":"Damian deGoa resigned as Director at Liquidia Corp.","evidence_excerpt":"Mr. deGoa’s concurrent resignation as the Company’s Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819576/000110465922000510/0001104659-22-000510-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}